Director Share Purchase

Time Finance PLC
23 October 2023
 

23 October 2023

Logo Description automatically generated

 

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

 

Director/PDMR Shareholding

 

Time Finance plc, the AIM listed independent specialist finance provider, announces that it was notified on 20 October 2023 that Ron Russell, Non-Executive Director of the Company, purchased 120,000 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") at a weighted average price of 29.52 pence per share, via UK Private Healthcare Ltd, on that same day. Ron Russell, together with his spouse, are interested in 50.01% of UK Private Healthcare Ltd's issued share capital.

 

Following this transaction, Ron Russell has a total beneficial interest in 11,542,788 Ordinary Shares, including those held by his spouse, representing 12.48% of the Company's issued share capital.

 

The information below, set out in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

- Ends -

 

 

For further information, please contact:

 

Time Finance plc

Ed Rimmer, Chief Executive Officer                                                                                         01225 474230

James Roberts, Chief Financial Officer                                                                                    01225 474230

 

Cavendish Securities plc (NOMAD and Broker)

Ben Jeynes / Dan Hodkinson (Corporate Finance)                                                                0207 220 000

Michael Johnson / George Budd (Sales)

 

Walbrook PR                                                                                                                              0207 9338780

Paul Vann / Joe Walker                                                                                                             07768 807631

paul.vann@walbrookpr.com

 

 

About Time Finance:

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs concentrating on asset, loan and invoice finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website: www.timefinance.com.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

UK Private Healthcare Ltd

2

Reason for the notification

a)

Position/status

PCA of Ron Russell, Non-Executive Director

 

 

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) 

Name

Time Finance plc

b)

LEI

213800VG3QJGBP2MKR86

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 Identification code

Ordinary Shares of 10p each

 

ISIN: GB00BCDBXK43

 

 

b)

Nature of the transaction

On market purchases of Ordinary Shares

 

 

c)

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

29.26p

29.79p

29.50p

50,000

50,000

20,000


d)

Aggregated information

- Aggregated volume

 

- Price

 

120,000

 

£35,438

 

e)

Date of the transaction

20 October 2023

 

 

f)

Place of the transaction

LONDON STOCK EXCHANGE (AIMX)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings